Scott Kopetz
MD, PhD
Professor of Gastrointestinal Medical Oncology
👥Biography 个人简介
Scott Kopetz at MD Anderson is a world leader in BRAF-mutant colorectal cancer, leading the BEACON-CRC trial that established encorafenib plus cetuximab as standard of care for BRAF V600E CRC. His laboratory work on RAS/RAF signaling in CRC has defined feedback mechanisms that distinguish colon BRAF from melanoma BRAF tumors. He has been instrumental in defining predictive biomarkers for targeted therapy in CRC. His translational research programs have shaped the precision medicine approach to advanced colorectal cancer.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Scott Kopetz 的研究动态
Follow Scott Kopetz's research updates
留下邮箱，当我们发布与 Scott Kopetz（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment